For consumers
(1300 633 424)
Mon-Fri | 9am-5pm AEST
Your call will be answered by healthdirect Australia
For health professionals
Find out the active ingredient and other brand names of your medicines with the NPS Medicine Name Finder
For a medicinewise Australia
Independent. Not-for-profit. Evidence based.
Site Tools
Migraine - Independent medicine & health information for consumers & professionals Migraine
Show health professional infoLatest independent information about migraine, including medicines and non-drug treatments, written and reviewed by experts in Australia.
| Filter by audience: | |
|---|---|
| All | |
| Consumer | |
| Health professional | |
| Researchers & evaluators | |
| Members & stakeholders | |
| Other | |
| Title | Description | Type | Audience  |
Date* |
|---|---|---|---|---|
Eletriptan (Relpax) and other triptans for migraine |
Eletriptan (Relpax) and other triptans for migraine |
Professional publication - NPS RADAR - Brief item | Health Professionals | 2010-10-01 00:00:00 |
Sumatriptan fast-disintegrating tablets (Imigran FDT) and substitution with other PBS-listed brands |
Sumatriptan fast-disintegrating tablets (Imigran FDT) and substitution with other PBS-listed brands. |
Professional publication - NPS RADAR - Brief item | Health Professionals | 2012-03-01 00:00:00 |
Case study 35 report: Migraine in primary care |
Patient presents with severe migraine which has not responded to aspirin. She has a 10 year history of migraines, with recent increasing frequency. |
Professional activity - Case study report | Health Professionals | 2005-05-01 00:00:00 |
Case study 35: Migraine in primary care |
Patient presents with severe migraine which has not responded to aspirin. She has a 10 year history of migraines, with recent increasing frequency. |
Professional activity - Case study | Health Professionals | 2005-02-03 00:00:00 |
Case study 50 report: Individualising hormonal contraception |
Patient presents with persistent throbbing headache experienced since starting a combined oral contraceptive (ethinyloestradiol with norethisterone). |
Professional activity - Case study report | Health Professionals | 2007-12-01 00:00:00 |
Articles on headache & migraine drugs from NPS RADAR |
Get independent, accurate, evidence-based info on headache & migraine drugs. Written for doctors, pharmacists & other health professionals. |
Topic overview | Health Professionals | 2009-10-28 00:00:00 |
Medicines for headache and migraine |
Learn about the differences between headaches and migraine, ways of treating both conditions, and problems with codeine in combination painkillers. |
Consumer publication - MedicinesTalk | Consumers | 2005-09-01 00:00:00 |
NPS News 38: Headache and migraine |
Diagnosing headaches, and preventive treatment for headaches and migraines focusing on drug and non-drug approaches. |
Professional publication - NPS News | Health Professionals | 2005-01-01 00:00:00 |
Rizatriptan (Maxalt) 10 mg wafers for migraine, and revised listings for other 5HT1 agonists (‘triptans’) |
Rizatriptan (Maxalt) 10 mg wafer for migraine, and revised listings for other 5HT1 agonists (‘triptans’) |
Professional publication - NPS RADAR - Brief item | Health Professionals | 2010-04-01 00:00:00 |
Topiramate (Topamax) for migraine prevention |
Review of topiramate (Topamax) for migraine prevention as second-line agent, with emphasis on non-drug therapies and safety issues. |
Professional publication - NPS RADAR - Review | Health Professionals | 2007-12-01 00:00:00 |
Triptans for migraine |
PBAC has increased maximum quantity of naratriptan, sumatriptan, and zolmitriptan to 4 tablets with 5 repeats for patients with more than one migraine each month. |
Professional publication - NPS RADAR - Review | Health Professionals | 2004-02-01 00:00:00 |
Information on this website is published by NPS — an independent, evidence based, not-for-profit organisation funded by the Australian Government Department of Health and Ageing.
NPS develops its information under the guidance of experts in their field, editorial panels, expert reviewers and consumers. Find out more about how we develop our content.
Date published: 2010-12-17 00:00:00
Reasonable care is taken to provide accurate information at the date of creation. This information is not intended as a substitute for medical advice from a qualified health professional. Health professionals should rely on their own expertise and enquiries when providing medical advice or treatment. Where permitted by law, NPS disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer.
References to brands should not be taken as an endorsement by NPS.
